Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers.
about
Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cells.Towards a molecular understanding of the biosynthesis of amaryllidaceae alkaloids in support of their expanding medical use.Haemanthus coccineus extract and its main bioactive component narciclasine display profound anti-inflammatory activities in vitro and in vivoFungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure-activity relationship and unique pyrrolylation of primary amines.Narciclasine attenuates diet-induced obesity by promoting oxidative metabolism in skeletal muscle.Jonquailine, a new pretazettine-type alkaloid isolated from Narcissus jonquilla quail, with activity against drug-resistant cancer.Antiproliferative activities of Amaryllidaceae alkaloids from Lycoris radiata targeting DNA topoisomerase I.Synthesis of Amaryllidaceae Constituents and Unnatural Derivatives.Comparative Analysis of Amaryllidaceae Alkaloids from Three Lycoris Species.Amaryllidaceae alkaloids: Absolute configuration and biological activity.5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cellsAmaryllidaceae and Sceletium alkaloids.Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells.Narciclasine, a potential allelochemical, affects subcellular trafficking of auxin transporter proteins and actin cytoskeleton dynamics in Arabidopsis roots.Screening for inhibitors of topoisomerase I from Lycoris radiata by combining ultrafiltration with liquid chromatography/mass spectrometry.
P2860
Q27335770-59F97DA7-9815-4264-BE22-261FD236F2BEQ34348023-516C7C7A-C63A-4EE2-A224-48B7C97299E3Q35571926-1AC39F0A-CC15-48C0-9177-643BBAB212AAQ36119458-8EF22247-EB10-4803-8F69-A4F0A7ADC08EQ36282422-62E6EC6D-98F1-4236-80FA-2F019120981FQ37088195-3E899C34-8525-4C0A-BD68-5EAE67B65DBFQ37476099-B2674F5F-7047-42A5-A8F2-B17B4B888C7BQ38771107-7EA3908E-6FA6-4AE5-9A64-2B888907625AQ38929611-E88548EC-6644-4538-BA7B-D028703E5A34Q38947527-11055E59-91AF-4D50-878E-38F3240ED9A9Q41744145-41C5A7A6-7BD5-4BCC-8BA5-255837D4D6ECQ46471242-0FBF5950-04DA-45A9-8EB5-5B4AEE3DD9F9Q50154429-E32BE6C2-AB5D-4908-B040-C043E9FBB9B8Q52662378-E0FB4E05-D27F-4C2F-BE3F-D88D1EEE8A83Q53032767-6155F2B2-AB8D-444F-BAEC-3F2ADF9AF895
P2860
Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Narciclasine as well as other ...... agents against brain cancers.
@en
Narciclasine as well as other ...... agents against brain cancers.
@nl
type
label
Narciclasine as well as other ...... agents against brain cancers.
@en
Narciclasine as well as other ...... agents against brain cancers.
@nl
prefLabel
Narciclasine as well as other ...... agents against brain cancers.
@en
Narciclasine as well as other ...... agents against brain cancers.
@nl
P2093
P2860
P356
P1476
Narciclasine as well as other ...... agents against brain cancers.
@en
P2093
Alexander Kornienko
Antonio Evidente
Florence Lefranc
Gwendoline Van Goietsenoven
Robert Kiss
Véronique Mathieu
P2860
P304
P356
10.1002/MED.21253
P577
2012-03-14T00:00:00Z